rs3827657

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001277115.2(DNAH11):​c.3630G>A​(p.Gln1210Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.81 in 1,583,142 control chromosomes in the GnomAD database, including 521,196 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.79 ( 47148 hom., cov: 31)
Exomes 𝑓: 0.81 ( 474048 hom. )

Consequence

DNAH11
NM_001277115.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.499

Publications

22 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-21601600-G-A is Benign according to our data. Variant chr7-21601600-G-A is described in ClinVar as Benign. ClinVar VariationId is 163102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.499 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.828 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.3630G>A p.Gln1210Gln synonymous_variant Exon 18 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.3630G>A p.Gln1210Gln synonymous_variant Exon 18 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5

Frequencies

GnomAD3 genomes
AF:
0.786
AC:
119404
AN:
151952
Hom.:
47106
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.740
Gnomad AMI
AF:
0.857
Gnomad AMR
AF:
0.712
Gnomad ASJ
AF:
0.690
Gnomad EAS
AF:
0.801
Gnomad SAS
AF:
0.701
Gnomad FIN
AF:
0.820
Gnomad MID
AF:
0.699
Gnomad NFE
AF:
0.834
Gnomad OTH
AF:
0.787
GnomAD2 exomes
AF:
0.772
AC:
182139
AN:
235816
AF XY:
0.774
show subpopulations
Gnomad AFR exome
AF:
0.732
Gnomad AMR exome
AF:
0.649
Gnomad ASJ exome
AF:
0.686
Gnomad EAS exome
AF:
0.792
Gnomad FIN exome
AF:
0.826
Gnomad NFE exome
AF:
0.830
Gnomad OTH exome
AF:
0.781
GnomAD4 exome
AF:
0.812
AC:
1162082
AN:
1431072
Hom.:
474048
Cov.:
43
AF XY:
0.808
AC XY:
570938
AN XY:
706308
show subpopulations
African (AFR)
AF:
0.724
AC:
23667
AN:
32678
American (AMR)
AF:
0.657
AC:
27562
AN:
41938
Ashkenazi Jewish (ASJ)
AF:
0.684
AC:
17415
AN:
25478
East Asian (EAS)
AF:
0.759
AC:
29597
AN:
38984
South Asian (SAS)
AF:
0.691
AC:
57158
AN:
82770
European-Finnish (FIN)
AF:
0.832
AC:
43966
AN:
52848
Middle Eastern (MID)
AF:
0.691
AC:
3911
AN:
5664
European-Non Finnish (NFE)
AF:
0.835
AC:
911467
AN:
1091772
Other (OTH)
AF:
0.803
AC:
47339
AN:
58940
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
10172
20344
30516
40688
50860
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20938
41876
62814
83752
104690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.786
AC:
119496
AN:
152070
Hom.:
47148
Cov.:
31
AF XY:
0.780
AC XY:
57984
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.741
AC:
30708
AN:
41468
American (AMR)
AF:
0.711
AC:
10861
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.690
AC:
2391
AN:
3466
East Asian (EAS)
AF:
0.801
AC:
4133
AN:
5160
South Asian (SAS)
AF:
0.701
AC:
3379
AN:
4820
European-Finnish (FIN)
AF:
0.820
AC:
8666
AN:
10564
Middle Eastern (MID)
AF:
0.707
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
0.834
AC:
56702
AN:
68000
Other (OTH)
AF:
0.790
AC:
1666
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1314
2628
3942
5256
6570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.806
Hom.:
91107
Bravo
AF:
0.776
Asia WGS
AF:
0.798
AC:
2778
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gln1210Gln in exon 18 of DNAH11: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 25.3% (958/3782) of African American chromosomes from a broad population by the NHLBI Exome Seque ncing Project (http://evs.gs.washington.edu/EVS; dbSNP rs3827657). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 7 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.4
DANN
Benign
0.47
PhyloP100
-0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3827657; hg19: chr7-21641218; COSMIC: COSV60946186; API